Aridis pharmaceuticals reports third quarter results

Aridis pharmaceuticals announces third quarter 2019 results.q3 loss per share $0.87.q3 earnings per share estimate $-0.33 -- refinitiv ibes data.total cash and cash equivalents as of september 30, 2019 was $17.3 million.

ARDS Ratings Summary

ARDS Quant Ranking